Your browser doesn't support javascript.
loading
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.
Andersson, Anna K; Ma, Jing; Wang, Jianmin; Chen, Xiang; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Parker, Matthew; Easton, John; Huether, Robert; Kriwacki, Richard; Rusch, Michael; Wu, Gang; Li, Yongjin; Mulder, Heather; Raimondi, Susana; Pounds, Stanley; Kang, Guolian; Shi, Lei; Becksfort, Jared; Gupta, Pankaj; Payne-Turner, Debbie; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi; Song, Guangchun; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Cheng, Cheng; Pei, Deqing; Sutton, Rosemary; Venn, Nicola C; Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel; Heldrup, Jesper; Fioretos, Thoas; Lu, Charles; Ding, Li; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G; Mardis, Elaine R; Wilson, Richard K; Gruber, Tanja A; Zhang, Jinghui; Downing, James R.
Afiliação
  • Andersson AK; 1] Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. [2] Department of Clinical Genetics, Lund University, Lund, Sweden.
  • Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Wang J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Chen X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Gedman AL; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Dang J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Nakitandwe J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Holmfeldt L; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Parker M; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Easton J; Pediatric Cancer Genome Project Laboratory, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Huether R; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Kriwacki R; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Rusch M; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Wu G; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Li Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Mulder H; Pediatric Cancer Genome Project Laboratory, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Raimondi S; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Pounds S; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Kang G; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Shi L; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Becksfort J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Gupta P; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Payne-Turner D; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Vadodaria B; Pediatric Cancer Genome Project Laboratory, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Boggs K; Pediatric Cancer Genome Project Laboratory, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Yergeau D; Pediatric Cancer Genome Project Laboratory, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Manne J; Pediatric Cancer Genome Project Laboratory, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Song G; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Edmonson M; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Nagahawatte P; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Wei L; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Pei D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Sutton R; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
  • Venn NC; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
  • Chetcuti A; Tumor Bank, Children's Cancer Research Unit, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
  • Rush A; Tumor Bank, Children's Cancer Research Unit, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
  • Catchpoole D; Tumor Bank, Children's Cancer Research Unit, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
  • Heldrup J; Department of Pediatrics, Skåne University Hospital, Lund, Sweden.
  • Fioretos T; Department of Clinical Genetics, Lund University, Lund, Sweden.
  • Lu C; 1] Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. [2] Genome Institute, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Ding L; 1] Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. [2] Genome Institute, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Pui CH; 1] Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. [2] Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Shurtleff S; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Mardis ER; 1] Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. [2] Genome Institute, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Wilson RK; 1] Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. [2] Genome Institute, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Gruber TA; 1] Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. [2] Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Zhang J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Downing JR; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Nat Genet ; 47(4): 330-7, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25730765
ABSTRACT
Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leukemia with a poor prognosis. To define its mutational landscape, we performed whole-genome, exome, RNA and targeted DNA sequencing on 65 infants (47 MLL-R and 18 non-MLL-R cases) and 20 older children (MLL-R cases) with leukemia. Our data show that infant MLL-R ALL has one of the lowest frequencies of somatic mutations of any sequenced cancer, with the predominant leukemic clone carrying a mean of 1.3 non-silent mutations. Despite this paucity of mutations, we detected activating mutations in kinase-PI3K-RAS signaling pathway components in 47% of cases. Surprisingly, these mutations were often subclonal and were frequently lost at relapse. In contrast to infant cases, MLL-R leukemia in older children had more somatic mutations (mean of 6.5 mutations/case versus 1.3 mutations/case, P = 7.15 × 10(-5)) and had frequent mutations (45%) in epigenetic regulators, a category of genes that, with the exception of MLL, was rarely mutated in infant MLL-R ALL.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína de Leucina Linfoide-Mieloide / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína de Leucina Linfoide-Mieloide / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia